最新文章：伊维菌素和芬苯达唑的见证——一位来自德克萨斯州休斯顿的61岁男子，新确诊患有前列腺癌，在接受治疗3个月后报告说——他的格里森评分下降了！我真的不知道答案🤔故事：一名61岁的休斯顿男子，德克萨斯州，新近确诊前列腺癌，PSA值为3.5。2025年2月20日进行的活检显示，6个样本中存在癌细胞，格里森评分（Gleason score）为3+4=7。2025年3月，他开始了一个为期90天的课程：伊维菌素 1.5mg/kg/天芬苯达唑 1500 毫克/天3 个月后的结果：格里森评分从 7 分降至 6 分。“我做了新的前列腺活检，结果显示格里森评分是6分（3+3）。你们的治疗方案奏效了！这真是个巨大的成功，我现在只需要定期观察前列腺癌的进展。”我以前好几次都看到过这种情况，但因为不知道是怎么发生的，所以一直没有上报。前列腺癌在细胞层面可能会变得“不那么具有侵袭性”。这将是伊维菌素研究面临的挑战之一😃如果这种情况能够重现(I我们已经在几位前列腺癌患者身上看到过这种情况），如果我们能够弄清楚这是怎么发生的，那就太棒了！NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 61 year old Houston, Texas man with newly diagnosed Prostate Cancer reports after 3 months - his Gleason Score dropped!I really don't have an answer for this 🤔STORY:61 year old Houston, Texas man with newly diagnosed Prostate Cancer and PSA 3.5Biopsy on February 20, 2025 showed cancer in 6 samples with a Gleason score of 3+4=7In March, 2025 he started a 90 day course of:Ivermectin 1.5mg/kg/dayFenbendazole 1500mg/dayResults after 3 months: Gleason score dropped from 7 to 6."I have had a new prostate biopsy which indicated a Gleason Score of 6 (3+3). Your protocol worked! A great success as I am now on the simple "monitor" status for prostate cancer"I have seen this happen before several times now but have not reported it before as I don’t know how this happens.The prostate cancer can become “less aggressive” at the cellular level.This will be one of the Ivermectin research challenges to take on 😃If this is replicated (I have seen this already in several Prostate Cancer patients), it would be amazing if we can figure out how this happens!
